Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00021151
Status:
COMPLETED
Last Update Posted:
2014-01-09
First Post:
2001-07-11
Brief Title:
Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Study Overview
Official Title:
CAMPATH-1H Compassionate Treatment In Patients With PLL Who Have Failed At Least One Prior Regimen And CLL Patients Who Have Failed Fludarabine Therapy
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells Compassionate use refers to providing a drug to a patient on humanitarian grounds before the drug has received official approval
PURPOSE Compassionate use of Campath-1H in treating patients who have refractory prolymphocytic leukemia or chronic lymphocytic leukemia
PURPOSE Compassionate use of Campath-1H in treating patients who have refractory prolymphocytic leukemia or chronic lymphocytic leukemia
Detailed Description:
OBJECTIVES I Expand access to Campath-1H for patients with refractory prolymphocytic leukemia or chronic lymphocytic leukemia
OUTLINE Patients receive Campath-1H IV over 2 hours on days 1 3 and 5 Treatment repeats weekly for 4-12 weeks in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL Not specified
OUTLINE Patients receive Campath-1H IV over 2 hours on days 1 3 and 5 Treatment repeats weekly for 4-12 weeks in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL Not specified
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-G01-1977 | None | None | None |
| CWRU-ILEX-1999 | None | None | None |
| ILEX-CAM511-A1 | None | None | None |